BioNTech SE (BNTX) Interest & Investment Income (2018 - 2025)
BioNTech SE (BNTX) posted Interest & Investment Income of $115.9 million for Q4 2025, up 2.45% on a QoQ basis from $113.2 million in Q3 2025, and down 34.32% year-over-year from $176.5 million in Q4 2024.
BioNTech SE (BNTX) has 8 years of Interest & Investment Income data on file, last reported at $115.9 million in Q4 2025.
- In Q4 2025, Interest & Investment Income fell 34.32% year-over-year to $115.9 million; the TTM figure through Dec 2025 stood at $477.4 million (down 34.09% YoY), while the FY2025 annual figure was $478.9 million, down 32.5% from the prior year.
- Interest & Investment Income advanced to $115.9 million in Q4 2025, from $113.2 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $305.4 million in Q1 2022 and bottomed at -$1.4 million in Q3 2021.
- A 5-year average of $118.9 million and a median of $121.3 million in 2022 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2021 — Interest & Investment Income soared 3127884703.33% — and 2023, when it sank 71.07%.
- Year by year, Interest & Investment Income stood at $18.6 million in 2021, then jumped by 112.29% to $39.6 million in 2022, then surged by 340.86% to $174.5 million in 2023, then rose by 1.15% to $176.5 million in 2024, then plunged by 34.32% to $115.9 million in 2025.
- The last three Interest & Investment Income figures came in at $115.9 million (Q4 2025), $113.2 million (Q3 2025), and $119.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | 115.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 115.94 Mn |
| Sep 30, 2025 | 113.16 Mn |
| Jun 30, 2025 | 119.31 Mn |
| Mar 31, 2025 | 128.96 Mn |
| Dec 31, 2024 | 176.53 Mn |
| Sep 30, 2024 | 171.54 Mn |
| Jun 30, 2024 | 180.59 Mn |
| Mar 31, 2024 | 195.65 Mn |
| Dec 31, 2023 | 174.52 Mn |
| Sep 30, 2023 | 170.15 Mn |
| Jun 30, 2023 | 165.95 Mn |
| Mar 31, 2023 | 88.34 Mn |
| Dec 31, 2022 | 39.59 Mn |
| Sep 30, 2022 | 61.40 Mn |
| Jun 30, 2022 | 123.25 Mn |
| Mar 31, 2022 | 305.39 Mn |
| Dec 31, 2021 | 18.65 Mn |
| Sep 30, 2021 | 31.37 Mn |
| Jun 30, 2021 | -361,281.43 |
| Mar 31, 2021 | 29.91 Mn |
| Dec 31, 2020 | -0.60 |
| Mar 31, 2020 | 7.07 Mn |
| Dec 31, 2019 | -8.16 Mn |
| Sep 30, 2019 | 8.12 Mn |
| Dec 31, 2018 | 1.72 Mn |
| Sep 30, 2018 | 421,052.76 |